Imperial College London Featured PhD Programmes
Imperial College London Featured PhD Programmes
The University of Manchester Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Max Planck Society Featured PhD Programmes
"therapeutics"×
10 miles

therapeutics PhD Projects, Programs & Scholarships

We have 48 therapeutics PhD Projects, Programs & Scholarships

  • "therapeutics" ×
  • clear all
Order by 
Showing 1 to 10 of 48
  Fostering development of ‘smart’, responsive therapeutics against cancer-related microRNAs.
  Dr E Bichenkova, Prof D Clarke, Dr H Aojula
Applications accepted all year round

Funding Type

PhD Type

Short functional non-coding microRNAs are implicated in many types of cancer, and thus can be used as biological targets for development of more selective and powerful anticancer therapies.
  Nucleic acid aptamers for diagnostics, therapeutics and DNA nanotechnology
  Dr J Tanner
Applications accepted all year round

Funding Type

PhD Type

Nucleic acid aptamers can be evolved to bind specifically to molecules and have particular functions in a range of applications. They are also wonderful tools as adaptors and functional units in DNA nanotechnology.
  A novel class of excipients for stabilizing protein therapeutics
  Dr R Curtis, Dr J Warwicker
Applications accepted all year round

Funding Type

PhD Type

Biopharmaceutical proteins constitute a growing proportion of the drug catalogue for virtually all major pharmaceutical companies.
  Bioinformatics for Personalized and Precision Neoantigen Therapeutics in Cancer
  Prof T Hupp, Dr JA Alfaro
Applications accepted all year round

Funding Type

PhD Type

Despite the success of immune checkpoint inhibitors in the clinic, most cancer patients do not respond, and even among responders therapeutic resistance is a problem.
  Centres for Doctoral Training - 4 Year PhD Studentships

Funding Type

PhD Type

The Engineering and Physical Sciences Research Council (EPSRC) is the main UK government agency for funding research and training in engineering and the physical sciences, investing more than £850m a year.
  Characterising surface properties of protein biopharmaceutical molecules
  Dr A Golovanov, Dr J Warwicker
Applications accepted all year round

Funding Type

PhD Type

Protein biologicals have great potential for the effective treatment of a wide range of diseases. However, aggregation and instability are inherent issues with all protein pharmaceuticals, which is a problem that can limit their utility and developability.
  Discovery of chemical and biological tools to probe hypoxic solid tumours
  Research Group: Institute of Cancer Therapeutics
  Dr K Pors, Dr J Elies Gomez
Applications accepted all year round

Funding Type

PhD Type

A major challenge in cancer therapy is to develop therapeutic agents that selectively target tumour cells. One avenue towards the development of more selective cancer therapies is to exploit the unique physiological properties of solid tumours using prodrug approaches.
  Structure and function of enzyme complexes involved in post-transcriptional gene regulation
  Dr G S Winkler
Applications accepted all year round

Funding Type

PhD Type

Many proteins in human cells function as part of high molecular weight multi-subunit assemblies. The structure and function of such large molecular machines is often difficult to characterise due to their complexity, low abundance and structural dynamics.
  Therapeutic potential of microRNAs in medullary thyroid carcinoma
  Prof G. Hutvagner
Applications accepted all year round

Funding Type

PhD Type

The Project. Medullary thyroid cancer is a rare, aggressive neuroendocrine tumour. Treatment of MTC poses a major challenge due to its propensity of early metastasis and no available adjuvant systemic treatment options.
  Genome mining of novel antimicrobial natural products from new bacterial strains
  Dr H Deng, Prof M Jaspars
Applications accepted all year round

Funding Type

PhD Type

Antimicrobial resistance (AMR) is rising to dangerously high levels in all parts of the world. In Europe alone, drug-resistant bacteria are estimated to cause 25,000 deaths annually and cost more than US$1.5 billion every year in healthcare expenses and productivity losses.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.